GlassScriptPhysician profile
John F Rupp
NPI 1598769473
$23,666.09
in general payments reported to CMS, 2019-2025
43 companies · $3,597 in 2025
The $3,597 reported for 2025 was more than what 87% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,423 · 2020: $2,482 · 2021: $3,053 · 2022: $4,046 · 2023: $4,592 · 2024: $3,474 · 2025: $3,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,532.23 |
| Education | $129.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,941.91 | 2019-2025 | Rinvoq, Skyrizi, Botox |
| Sun Pharmaceutical Industries INC. | $2,507.67 | 2019-2025 | Winlevi, Ilumya, Blu-U |
| Janssen Biotech, INC. | $1,964.91 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $1,650.01 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $1,428.15 | 2019-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $1,227.40 | 2019-2025 | |
| Leo Pharma INC. | $1,061.75 | 2019-2025 | Adbry, Anzupgo |
| Mayne Pharma Commercial LLC | $1,050.00 | 2019-2025 | |
| Amgen INC. | $1,047.83 | 2020-2025 | Otezla, Otezla |
| Pfizer INC. | $970.46 | 2020-2025 | |
| Genzyme Corporation | $841.98 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $787.66 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $601.49 | 2019-2025 | Dupixent |
| Dermavant Sciences, INC. | $593.34 | 2023-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $587.28 | 2019-2025 | Arazlo, Cabtreo |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.